MedPath

Effectiveness and Safety of Bulkamid® as Bulking Agent for the Treatment of Female Urinary Incontinence

Not Applicable
Completed
Conditions
Urinary Incontinence
Registration Number
NCT00333073
Lead Sponsor
Contura
Brief Summary

To assess effectiveness of Bulkamid® injection in females suffering from stress or mixed (stress and urge) urinary incontinence after 12 months follow up period

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
125
Inclusion Criteria
  • Informed consent
  • Symptomatic stress or mixed urinary incontinence for at least 12 months
  • Having at least 1 incontinence episode per day over three days
Exclusion Criteria
  • Regular or intermittent users of an urethral catheter
  • Pregnant women
  • Suffer from severe allergies or anaphylaxis
  • Suffer from autoimmune diseases or any unstable or sever cardio-vascular disease
  • History of any cancer within the last 5 years
  • Previous surgery for the treatment of urinary incontinence, including bulking

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Subjective responder rate after 12 months follow-up12 months
Secondary Outcome Measures
NameTimeMethod
ICIQBaseline, treatment, 1-, 6-, 12- and 24-months
24 hour urine leakageBaseline, treatment, 1-, 6-, 12- and 24-months
daily incidence of incontinence episodesBaseline, treatment, 1-, 6-, 12- and 24-months
QolBaseline, treatment, 1-, 6-, 12- and 24-months

Trial Locations

Locations (10)

Skejby Sygehus

🇩🇰

Aarhus, Denmark

KAS Glostrup

🇩🇰

Glostrup, Denmark

Helsinki University Central Hospital

🇫🇮

Helsinki, Finland

DRK Gemeinnützige Krankenhaus Gmbh

🇩🇪

Chemnitz, Germany

Karolinska Institutet

🇸🇪

Stockholm, Sweden

Södersjukhuset

🇸🇪

Stockholm, Sweden

Worthing Hospital

🇬🇧

Worthing, West Sussex, United Kingdom

Birmingham Women´s Hospital

🇬🇧

Birmingham, United Kingdom

University Hospital of Hartlepool

🇬🇧

Hartlepool, United Kingdom

St. George´s Hospital

🇬🇧

London, United Kingdom

Skejby Sygehus
🇩🇰Aarhus, Denmark

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.